CC-122 | B1650

CC-122 is a novel agent for DLBCL with antitumor and immunomodulatory activity.CC-122 binds CRBN and degrades Aiolos and Ikaros resulting in a mimicry of IFN signaling and apoptosis in DLBCL.

CC-122 is a novel agent for DLBCL with antitumor and immunomodulatory activity.CC-122 binds CRBN and degrades Aiolos and Ikaros resulting in a mimicry of IFN signaling and apoptosis in DLBCL.

B1650 | CC-122 DataSheet

Alternate Name/Synonyms: CC-122; CC122; CC 122; Avadomide; 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione; 2,6-Piperidinedione, 3-(5-amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-

Appearance: Solid

Formulation: N/A

CAS Number: 1015474-32-4

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₄H₁₄N₄O₃

Molecular Weight: 286.29

Cell-Permeable?: Yes

Purity: >98%

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A novel agent for DLBCL

MDL Number: NA

PubChem CID: 24967599

SMILES: CC1=NC2=C(C(=CC=C2)N)C(=O)N1C3CCC(=O)NC3=O

InChi: InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20)

InChi Key: RSNPAKAFCAAMBH-UHFFFAOYSA-N